Bristol Myers Squibb (BMY) Bets On AI Drug Discovery And Wider Trial Access

AI Earnings (Google News)October 23, 2026en

AI Earnings (Google News)

AI Global Wire

Bristol Myers Squibb (NYSE:BMY) has entered multi year AI drug development partnerships with Pathos AI and Tempus AI. The agreement gives Bristol Myers Squibb exclusive access to Pathos AI's discovery ...

This is a short summary published by AI Global Wire. The full article is owned and hosted by AI Earnings (Google News) — open it there to read it in full.